Assertio Holdings (ASRT) Accumulated Expenses (2019 - 2026)
Assertio Holdings' (ASRT) quarterly Accumulated Expenses came in at $18.5 million in Q1 2026, down 44.05% year-on-year from $33.0 million in Q1 2025, and up 29.43% quarter-over-quarter from $14.3 million in Q4 2025.
Assertio Holdings (ASRT) Accumulated Expenses (2019 - 2026) Analysis & Trends
Assertio Holdings has disclosed Accumulated Expenses across 8 years of filings, most recently posting $18.5 million for Q1 2026.
- Accumulated Expenses for Q1 2026 came in at $18.5 million, down 44.05% year-over-year; the trailing twelve-month figure through Mar 2026 was $18.5 million (down 44.05% YoY), and the FY2025 annual result was $14.3 million, down 24.22% from the prior year.
- Accumulated Expenses came in at $18.5 million for Q1 2026 at Assertio Holdings, up from $14.3 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $33.0 million in Q1 2025 to a low of $10.3 million in Q2 2023.
- The 5-year median for Accumulated Expenses is $15.4 million (2022), against an average of $17.0 million.
- Across the five-year window, Accumulated Expenses surged 114.51% in 2025 and tumbled 44.05% in 2026, its largest moves.
- Assertio Holdings' Accumulated Expenses stood at $12.2 million in 2022, then soared by 49.52% to $18.2 million in 2023, then rose by 3.48% to $18.8 million in 2024, then slipped by 24.22% to $14.3 million in 2025, then climbed by 29.43% to $18.5 million in 2026.
- The last three Accumulated Expenses figures came in at $18.5 million (Q1 2026), $14.3 million (Q4 2025), and $16.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Assertio Holdings | 150.94 Mn | 79.37 Mn | 7.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.49 Mn |
| Dec 31, 2025 | 14.28 Mn |
| Sep 30, 2025 | 16.26 Mn |
| Jun 30, 2025 | 31.06 Mn |
| Mar 31, 2025 | 33.04 Mn |
| Dec 31, 2024 | 18.85 Mn |
| Sep 30, 2024 | 12.96 Mn |
| Jun 30, 2024 | 15.12 Mn |
| Mar 31, 2024 | 15.40 Mn |
| Dec 31, 2023 | 18.21 Mn |
| Sep 30, 2023 | 22.07 Mn |
| Jun 30, 2023 | 10.28 Mn |
| Mar 31, 2023 | 10.80 Mn |
| Dec 31, 2022 | 12.18 Mn |
| Sep 30, 2022 | 10.99 Mn |
| Jun 30, 2022 | 13.23 Mn |
| Mar 31, 2022 | 15.39 Mn |
| Dec 31, 2021 | 14.70 Mn |
| Sep 30, 2021 | 13.78 Mn |
| Jun 30, 2021 | 22.87 Mn |